Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban

ConclusionThis small study suggests that it is likely that DOAC Stop can be used in laboratories to screen for coagulopathy or lupus anticoagulants in samples containing rivaroxaban or apixaban. Care should be taken in the interpretation of results since complete reversal of the anti ‐Xa effect did not occur in every sample.
Source: Clinical and Laboratory Haematology - Category: Hematology Authors: Tags: ORIGINAL ARTICLE Source Type: research